Overview (22 Sep 2026)
Aarey Drugs & Pharmaceuticals Ltd
AAREYDRUGS
INE198H01019

Pharmaceuticals
0.49

Prev. Close
Previous Close
102.06
Current Close
102.55
Current High
103.8
Current Low
101.11
52 Week High
104.1
52 Week Low
50.4
Resistance 1
103.87
Resistance 2
105.18
Support 1
101.18
Support 2
98.49
Std Deviation
9.06%
DMA 200
77.79
DMA 50
86.04
DMA 20
94.35
Fundamentals and Ratios
Standalone
Trailing EPS
1.39
Forwad EPS
1.48
Trailing P/E
73.78
Forward P/E
69.29
PEG Ratio
-9.24
Mkt. Cap (Cr)
Market Cap (Cr)
290.77
Total Debt(Cr)
Tot. Debt(Cr)
49.96
Reserve (Cr)
121.97
Book Value
53.15
P/BV Ratio
1.93
ROCE(%)
5.00
ROE
7.00

 

Financial Result
Standalone
TypeJun-26Mar-26Dec-25Sep-25Jun-25FY25-26
Revenue44.63189.4796.4384.16102.21472.27
Other Income1.72-0.434.180.791.556.10
Total Income46.34189.04100.6184.96103.76478.37
Interest1.671.780.921.261.045.00
Expenditure-45.82-187.76-99.69-83.47-102.03-472.95
PBDT0.000.000.000.000.000.00
Depreciation-0.85-0.85-0.83-0.69-0.49-2.85
PBT0.521.280.921.481.735.41
Tax0.510.280.35-0.46-0.36-1.45
Equity28.4528.450.000.0028.4528.45
OPM1.120.680.961.761.671.13
Net Profit1.021.561.281.021.373.97
NPM2.20.831.331.221.320.83
EPS0.360.550.20.360.481.39
Consolidated
TypeFY25-26
Revenue472.269
Other Income6.10
Total Income478.37
Interest5.00
Expenditure-472.95
PBDT0.00
Depreciation-2.85
PBT5.41
Tax-1.45
Equity28.45
OPM1.13
Net Profit3.97
NPM0.83
EPS1.39
Annual Reports

Corporate Action
Quarterly Result
Dividend
YearDividend TypeAmountRemarkEx Date
2019Interim Divvidend0.10Interim Dividend - Rs. - 0.100013 Dec 2018
Bonus
YearRatioRemarkEx Date
20121:5Bonus issue 1:525 Jun 2012
Split

Mutual Fund Holddings